论文部分内容阅读
Objective To examine the brain metabolic changes in WD patients receiving copper chelation by us-ing1HMRS.Methods Thirty-nine patients with WD was randomly divided into four groups:non-brain type group(18cases),brain type prior-treatment group and short-term
Objective To examine the brain metabolic changes in WD patients receiving copper chelation by us-ing1HMRS.Methods Thirty-nine patients with WD was differentiated into four groups: non-brain type group (18cases), brain type prior-treatment group and short- term